The Oxford Marfan Trial

NCT01949233 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Marfan Syndrome

Interventions

DRUG: Irbesartan 150-300mg capsules daily for 6 months
DRUG: Doxycycline 100-200mg capsules daily for 6 months
DRUG: Doxycycline placebo capsules daily for 6 months
DRUG: Irbesartan placebo capsules daily for 6 months

Sponsor

University of Oxford

Collaborators

[object Object]